申请人:BOWMAN Keith Andrew
公开号:US20200231620A1
公开(公告)日:2020-07-23
Among other things, the present disclosure provides technologies for oligonucleotide preparation, particularly chirally controlled oligonucleotide preparation, which technologies provide greatly improved crude purity and yield, and significantly reduce manufacturing costs.